Elizabeth Woodling is the Vice President of Quality Assurance at QED Therapeutics. Ms. Woodling brings more than 17 years of quality and regulatory experience in the biopharmaceutical and medical device industries, working in roles of increasing responsibility at Depomed, Elan Pharmaceuticals, and Medtronic Neurosurgery. Most recently, she was the Senior Director of Quality Assurance and Regulatory Affairs at Mateon Therapeutics where she developed and had oversight of the quality management system and regulatory affairs to support multiple oncology trials for two compounds. Her experience covers GXP quality systems, regulatory strategy and operations, and electronic document management systems. She received a B.S. with Honors in Cellular and Developmental Biology from the University of California at Santa Barbara.